Table 3

Timeline of the assessment of inflammatory and coagulation parameters relative to the administration of IL-6 antagonist

DayConventional laboratory parametersClotPro® testsBlood sample
0Inflammatory parameters, clinical biochemistry and conventional coagulation parametersEX, IN, FIB, TPA, RVV, ECA testsPlasma, serum
Administration of IL-6 antagonist
24 hoursInflammatory parameters, clinical biochemistry and conventional coagulation parametersEX, IN, FIB, TPA, RVV, ECA tests
48 hoursInflammatory parameters, clinical biochemistry and conventional coagulation parametersEX, IN, FIB, TPA, RVV, ECA testsPlasma, serum
5 daysInflammatory parameters, clinical biochemistry and conventional coagulation parametersEX, IN, FIB, TPA, RVV, ECA tests
7 daysInflammatory parameters, clinical biochemistry and conventional coagulation parametersEX, IN, FIB, TPA, RVV, ECA testsPlasma, serum
  • ECA-test, ecarin clotting assay test; EX-test, extrinsic coagulation pathway test; FIB-test, functional fibrinogen test; IN-test, intrinsic coagulation pathway test; RVV-test, Russell’s viper venom reagent test ; TPA-test, tissue plasminogen activator test.